Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing
Sunnyvale, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces expansion of its proprietary finger stick microarray allergy testing platform to a growing number of major market brands. Highly automated Arrayit technology is inherently suited to leveraging multiple brands and their unique venues and relationships to reach a larger number of allergy patients more quickly. Each brand serving major retail chains, large government agencies, medical clinics and doctor offices receive the same high-level testing support and treatment options through the company’s Patient Data Solutions (PDS) on-line allergy testing portal and therapeutics affiliates. Arrayit allergy brands expansion is increasingly allowing the 250,000 primary care physicians in the United States to more accurately diagnose and treat an estimated 60,000,000 (60 million) American allergy patients.